NET citrullinated histone 4 has additionally been to shown to be a significant target of serum antibodies and ACPA reactivity to cit-His4 peptides is commonly detected in RA patients, which correlates with anti-CCP2 levels (73). Here, PRTN3 is linked to rheumatoid arthritis.